Biotech AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team October 2, 2024
Biotech Resolution Therapeutics Announces Upcoming Presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024 October 1, 2024
Biotech New Beginnings, New Journey | Sanyou Opening of New 10,000-sqm Facility, Ushering in a New Era of Innovation for Bio Drugs September 29, 2024
Biotech AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer September 28, 2024
Biotech FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia September 27, 2024
Biotech CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight September 26, 2024
Biotech Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 September 25, 2024
Biotech Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia September 24, 2024